An evaluation of subcutaneous apomorphine for the treatment of Parkinson’s disease
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2020.1787379
Abstract: ABSTRACT Introduction Heterogeneity of symptoms and individual variability of progression characterizes Parkinson’s disease. Unmet therapeutic needs include a cure, disease modification, and improvement of available marketed dopamine-substituting compounds. Personalized treatment, tailored to the patients’ needs… read more here.
Keywords: treatment; disease; motor; subcutaneous apomorphine ... See more keywords